Category Archives: Cell Biology

Researchers Identify Enzyme Linked to Colitis – Rutgers Today

Rutgers-Newark study may help develop future treatments for inflammatory bowel disease Nan Gao, associate professor of cell biology in the Department of Biological Sciences, School of Arts and Sciences-Newark, discovered that an enzyme, which should stop bacterial growth in the digestive tract, instead stimulates inflammation in people with colitis.

Devyn Nunez, Shine Portrait Studio

An enzyme that usually stops bacterial growth in the large intestine stimulates inflammation in some people, resulting in ulcerative colitis a chronic digestive disease that affects more than 750,000 Americans, according to scientists at Rutgers University-Newark.

In a new study published inImmunity, lead author Nan Gao, associate professor of cell biology in the Department of Biological Sciences, School of Arts and Sciences-Newark, reports that in people with ulcerative colitis, the gut enzyme lysozyme, which normally functions to restrain bacterial growth, instead stimulates inflammation.

This results in the formation of ulcers and sores in the large intestine and rectum, hallmarks of the inflammatory bowel disease. Detecting these cells in the inner lining of the colon and rectum is a standard diagnostic feature of chronic intestinal inflammation.

This study demonstrated the existence of a delicate balance between inflammatory and anti-inflammatory factors in our intestines, said Gao, who conducted it with postdoctoral researcher Richard Yu and doctoral student Iyshwarya Balasubramanian. Insights about how to gain such beneficial immune balance may be useful for future intervention of inflammatory bowel disease.

In biochemical and genetic mouse laboratory studies, Gao and his team focused on Paneth cells, the main producers of lysozyme, which are typically found in the small intestine and rarely observed in the large intestine or healthy colon. In cases of patients with inflammatory bowel disease, which affects 1.6 million people in the United States, Paneth cells are often seen in the colon and rectum.

The frequent appearance of Paneth cells in the inflamed tissues of patients' colons is highly unusual and poorly understood, Gao said.

In the Rutgers-Newark study, scientists discovered that lysozyme secreted by Paneth cells located in colon results in suppressing the growth of certain bacterial species and results in an imbalance in the gut microbiome, which leads to intestinal inflammation.

In healthy individuals that have normal production of gut lysozyme, these bacteria flourish enabling an individual immune response that prevents colitis.

This delicate balance is achieved and maintained by a constant interaction between our body and the commensal microorganisms that play a significant role in digestion, metabolism, and the immune system, Gao said.

See the rest here:
Researchers Identify Enzyme Linked to Colitis - Rutgers Today

3D Cell Cultures Industry Report 2020-2025: Impact of COVID-19 on the World of Cell Culture – PRNewswire

DUBLIN, Aug. 19, 2020 /PRNewswire/ -- The "3D Cell Cultures: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The report includes:

Whether the discussion is about stem cells, tissue engineering, or microphysiological systems, their vital role in drug discovery, toxicology, and other areas leading to new product development, 3D cell culture is becoming the environment that will increasingly define the basis for future advances.

To mix metaphors, 3D cell culture is also cross-roads through which just about everything else passes on its way to building knowledgebases or introducing new products. This study is needed to bring together and make sense out of the broad body of information encompassed by 3D cell culture.

Three-dimensional cell culture has been used by researchers for many years now, with early adoption and now key roles in cancer and stem cells. Organ-on-a-chip technology, also known as microphysiological systems, is leading to dramatic breakthroughs. Also, stem cell research coupled with synthetic biology is opening new areas. This study is needed to provide a perspective on these advances.

Furthermore, classical toxicology testing programs have been in place for many decades, and over the past 20 years, animal welfare and scientific activities have spurred the development of in vitro testing methods. In silico methods are advancing in novel ways that need to be analyzed and considered in terms of their impacts on cell culture.

This report investigates the recent key technical advances in 3D cell culture equipment, raw materials, assay kits, analytical methods, and clinical research organization (CRO) services. It should also be pointed out that this report takes a somewhat different position on 2D cell culture. It has been criticized for its inadequacies and the misleading information it can produce. However, a review of industry practices makes it clear that it still has its place and will contribute to future advances in unexpected ways.

The company section looks at many of the suppliers who provide equipment, assays, cells, reagents, and services used in 3D cell culture. This study sought to understand business models and market maturity dynamics in greater depth as well as providing more quantitative analysis of their operations.

Key Topics Covered

Chapter 1 Introduction

Chapter 2 Summary

Chapter 3 Highlights and Issues

Chapter 4 Tissue and Cell Culture: Technology and Product Background

Chapter 5 Assays, Imaging and Analysis

Chapter 6 Regulation and Standardization

Chapter 7 3D Models for Cancer

Chapter 8 Landscape for Toxicology and Drug Safety Testing

Chapter 9 Stem Cell Landscape

Chapter 10 Regenerative Medicine: Organ Transplants and Skin Substitutes

Chapter 11 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/jesu26

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Link:
3D Cell Cultures Industry Report 2020-2025: Impact of COVID-19 on the World of Cell Culture - PRNewswire

Cell Imagers Market is Booming Worldwide 2020-2027 By Product Analysis, By Application, By End-Users, By Regional Outlook, By Top Companies and…

New Jersey, United States,- The Cell Imagers MarketResearch Report byVerified Market Research focuses on some of the vital aspects of the market such as Revenue Rate, Market Share, Key Regions, and Production as well as Key Players. This Cell Imagers report also provides the readers with detailed figures at which the Cell Imagers market was valued in the historical year and its expected growth in upcoming years. Besides, the analysis also forecasts the CAGR at which the Cell Imagers is expected to mount and major factors driving the markets growth. All the latest technological innovations, industry trends, and market data are provided in the Global Cell Imagers report for the forecast period. The in-depth view of the Cell Imagers industry on the basis of market size, market growth, opportunities, and development plans offered by the report analysis.

Additionally, this report offers an extensive analysis of the supply chain, regional marketing, opportunities, challenges, and market drivers for the accurate prediction of the global Cell Imagers market. The Cell Imagers report also provides an in-depth analysis regarding the methodology and research approach, data sources, and authors of the study. The Cell Imagers report also covers the details about the manufacturing data such as interview record, gross profit, shipment, and business distribution which can aid the consumer to know about the competitive landscape.

Furthermore, the report also offers an in-depth assessment of the Cell Imagers market by highlighting data on several aspects that may include opportunities, market drivers, as well as threats. However, this data can aid providers to make proper decision making before investing in the Cell Imagers market. In addition, the research report has been designed on the basis of an in-depth analysis of the target market along with inputs from market professionals. The report focuses on the comprehensive landscape of the market and growth prospects over the forecast period. The Cell Imagers market report also comprises a broad overview of the major retailers operating in the target market.

Major Companies Profiled in This Cell Imagers Market Report:

Cell Imagers Market Segmentation:

Global Cell Imagers Market, By Product

Equipment Consumables Software

Global Cell Imagers Market, By Application

Drug Discovery Developmental Biology Cell Biology Stem Cell Biology

Global Cell Imagers Market, By End User

Academic & Research Institutes Pharmaceutical & Biotechnology Companies Academic & Research Institutes

Geographically, the Cell Imagers market report is segmented as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. This analysis report similarly reduces the present, past, and future market business strategies, company extent, development, share, and estimate analysis having a place with the predicted circumstances. Moreover, the possible results and the exposure to the enhancement of the Cell Imagers market widely covered in this report.

Cell Imagers Market: Regional Analysis Includes:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Europe(Turkey, Germany, Russia UK, Italy, France)

North America (The United States, Mexico, and Canada)

South America(Brazil etc)

The Middle East and Africa(GCC Countries and Egypt)

This report also describes the key challenges and threats possible. The report presents a full description of the strengths, weaknesses, opportunities, and threats to the Cell Imagers market. The market report provides the analytical tools that help identify the key external and internal factors that should be considered for the growth of the market. The report also helps companies in marketing for tasks like identifying their prospective customers, building relationships with them, and retention.

Key Highlights of the Cell Imagers Market Report:

Thank you for reading our report. The report is available for customization based on chapters or regions. Please get in touch with us to know more about customization options, and our team will ensure you get the report tailored according to your requirements.

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll-Free: +1 (800)-7821768

Email: [emailprotected]

Read the original post:
Cell Imagers Market is Booming Worldwide 2020-2027 By Product Analysis, By Application, By End-Users, By Regional Outlook, By Top Companies and...

Life Science Reagent Extracts Market, 2019-2025 by Segmentation Based on Product, Application and Region – Scientect

In 2025, the market size of the Life Science Reagent Market is expected to touch million US$ xx million. The revenue registered in 2019 was US$ xx million, thus depicting a growth at a CAGR of xx% from 2019. While in China, the market size was valued at US$ xx million in the forecast base year, further projected to increase up to US$ xx million till the end of 2025, with a CAGR of xx% during forecast period.

In this report, 2019 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Life Science Reagent .

This report studies the global market size of Life Science Reagent , especially focusing on the key regions such as United States, European Union, China, and other geographical extents (Japan, Korea, India, and Southeast Asia).

For more insights into the Market, request a sample of this report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2562876&source=atm

This study presents the Life Science Reagent market production, revenue, market share, and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. The historical data breakdown for Life Science Reagent for 2014-2019 is provided in the report along with company projection for 2019 to 2025.

For top companies in United States, European Union, and China, this report investigates and analyzes the production, value, price, market share, and growth rate for the manufacturers, key data from 2019 to 2025.

The following manufacturers are covered:High Throughput Genomics Inc.Illumina Inc.Abbott LaboratoriesAbcamEmd MilliporeBiologCell SciencesLonza Group AgCell Signaling TechnologyThermo Fisher Scientific Inc.Trilink BiotechnologiesCepheid Inc.Olympus Corp.Biomyx TechnologyAbgent Inc.

Segment by RegionsNorth AmericaEuropeChinaJapanSoutheast AsiaIndia

Segment by TypeCell Biology ReagentsAnimal ModelsRecombinant ProteinsOthes

Segment by ApplicationStem Cell ResearchDNA ResearchRNA ResearchProtein DetectionOthers

For Information On The Research Approach Used In The Report, Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2562876&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1 describes Life Science Reagent product/service scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2 profiles the top manufacturers of Life Science Reagent market, with price, sales, revenue and global market share of Life Science Reagent from 2014 2019.

Chapter 3 analyses the Life Science Reagent competitive situation, sales, revenue. The global Life Science Reagent market shares of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4 showcases the Life Science Reagent breakdown data at the regional level, to discuss the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8, and 9 emphasize the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11 explain the segments by sales under type and application, with market shares and growth rate under each category, from 2014 to 2019.

Chapter 12 depicts Life Science Reagent market forecasts by region, type, and application, with sales and revenue projections, from 2019 to 2025.

Chapter 13 and 14 describe Life Science Reagent sales channel, distributors, customers, research findings and conclusion, appendix, and other data sources.

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2562876&licType=S&source=atm

For More Information Kindly Contact:

marketresearchhub

90 State Street,

Albany NY,

United States 12207

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [emailprotected]

See more here:
Life Science Reagent Extracts Market, 2019-2025 by Segmentation Based on Product, Application and Region - Scientect

Some Immune Cells Appear to ‘Know’ the Coronavirus, Even Though They’ve Never Met | Newsroom – UC Merced University News

By Lorena Anderson, UC Merced

Thousands of researchers across the globe are trying to find out how to stop the spread of novel coronavirus.

Having had the common cold appears to have programmed some peoples immune cells to recognize the coronavirus that causes COVID-19.

That discovery by an immunology team that includes a UC Merced alumnus could change scientists understanding of the virus behind the current pandemic.

Lorenzo Quiambao, who graduated with a bachelors of science degree in biology in 2016, is a research assistant at the La Jolla Institute of Immunology at UC San Diego. His team was working with cell samples taken from people in 2018, before COVID-19 was even known. By incubating them into the SARS-CoV-2 viruss proteins, they found that up to half of the donor T cells exhibited a cross-reactive memory response, even though they had never experienced COVID.

It could mean that exposures to other coronaviruses, such as the cold, give these people an immune advantage, or it could mean that when they get the novel coronavirus, they get sicker, Quiambao said. Or it might mean nothing. Well know much better in a month or two.

Lorenzo Quiambao, Class of 2016, plans to become a physician and continue research.

Quiambao, who is from Modesto, has a very personal reason for wanting to research SARS-CoV-2 right now. His mother, a nurse practitioner, contracted COVID-19. She has recovered and is back to treating patients, but the experience was frightening, he said.

She had mild symptoms heart palpitations and trouble breathing for a full 14 days, he said. It seemed to fade, get worse for a couple of days, and then go away.

Quiambao majored in biology with emphases on immunology and microbiology and said his research position in La Jolla has been a dream job. Hes applying to medical schools now in hopes of becoming a practicing physician who also conducts research.

He and his teammates detailed their latest findings in a new article in Science.

Quiambao said the information would probably be more applicable to developing a vaccine than a treatment. He and the other researchers sequenced the viruss genome and are working at top speed to see what else they can learn, such as how this cross-reactive memory response could affect asymptomatic people, or people who are repeatedly exposed, such as those in the health care industry.

This coronavirus is so new, we really know very little about it, he said. But the world is on pause while everyone is trying hard to find the answers. Our whole institute is focused on it right now. Weve been really fortunate to have NIH funding and generous donors who have given us all this equipment that allows us to do in weeks what would have taken months before.

Go here to read the rest:
Some Immune Cells Appear to 'Know' the Coronavirus, Even Though They've Never Met | Newsroom - UC Merced University News

Auxolytic’s Nutrient-Based Shut-Off Switch Boosts Cell Therapy Safety Without Transgenes – BioSpace

Auxolytic has developed a nutrient-based safety-switch for cell therapies that doesnt rely on introducing transgenes. The process, auxotrophy, uses the engineered inability of an organism to synthesize a compound required for its survival to allow physicians to turn off a gene therapy if serious side effects develop.

The work currently is in preclinical phases, in humanized cells in mice, and appears promising. When it advances to clinical applications, patients receiving cell therapies (such as CAR T, stem cell, and TCR therapies) containing this safety switch would be given supplements of a particular nutrient uridine, in this case. If the cell therapy went awry, patients could simply stop taking the uridine supplement and the cellular therapy would cease to function.

A paper published in Nature Biotechnology describes how the off switch could be engineered into cell therapies. Basically, it says, the approach knocks out the gene that disrupt(s) uridine monophosphate synthetase (UMPS) in the pyrimidine de novo synthesis pathway in cell lines, pluripotent cells, and primary human T cells.

This knockout makes proliferation of the cell therapy dependent on the external supply of uridine. Therefore, researchers can control cell growth by modulating the uridine supply in vitro and, importantly, in vivo after transplantation.

In the movie Jurassic Park, the dinosaurs were engineered to need lysine. If they escaped, there was no lysine to keep them alive. This therapy is very similar, founder and CEO James Patterson, M.D., Ph.D., told BioSpace.

Rather than lysine, Auxolytic uses uridine as the controlling nutrient. Uridine is important in carbohydrate metabolism and is found in yeast, tomatoes, broccoli, sugarcane and other foods, and also can be produced by the body when inadequate amounts are consumed in the diet.

The quantities available through the diet or produced by the body, however, arent high enough to sustain the engineered cells, Patterson said. Evidence comes from a rare genetic disease, orotic aciduria. Patients with that condition have a mutation in the UMPS gene that causes them to produce insufficient levels of the enzyme that breaks down orotic acid. They often die at very young ages if not supplied with quantities of pure uridine. This shows that a normal diet wont compensate.

Patients of cell therapies that incorporate Auxolytics nutrient-based safety switch likely would be able to eat their usual foods, but with nuridine added as a supplement. The approach Dr. Patterson developed hasnt been tested in patients yet.

This is the same nutrient I worked with in yeast, but now in human cells, Patterson said. Early work shows that only the engineered cell therapy would be affected by uridine modulation. Within one week of withdrawing the uridine, the engineered cells were inactive and unable to proliferate. Normal cells continued to function as usual.

At age 27, Patterson already has worked with many of the thought leaders in medicine and biomedical research while pursuing his M.D. and Ph.D. degrees at the University of Cambridge and the Francis Crick Institute. Beginning early during his university days, he performed research placements at the University of Zurich, The Gurdon Institute, The Whitehead Institute and The Cambridge Stem Cell Initiative.

This nutrient-based approach to controlling cell therapy is the direct result of that body of experience.

During my M.D./Ph.D. training, I became interested in cell therapy and its potential for curing patients, but there were safety risks. My Ph.D. work focused on yeast biology, studying how cells control their size. There, the idea of nutrient-based cell control was commonplace, but no one was working on this in human cells, he said. I became interested in science when I was very young, so during my undergraduate work I made sure I was thinking about the science being done in the labs in addition to what I was learning in lectures. Theres a difference.

Lectures lay the scientific foundation, but lab work is cutting-edge and forward-thinking.

I started working in labs when I was 19 in Zurich. I spent all my summers working in labs, asking a range of questions and working in lots of different systems, Patterson said.

Such broad exposure proved foundational for Auxolytic.

As you can see, this is a yeast technology. Thats not where you usually go to look for cell therapy ideas, he added.

He advises students early on to get into exciting labs that are doing interesting, fundamental science. Ask basic questions of how cells work, for example. You never know what youll find that could be applicable to the clinic. Jumping to clinical research (too early) causes you to lose the blue sky thinking.

Auxotyic, based in Cambridge, UK, is, for now, a virtual company of onebut with ample advisors.

Theyve helped along the way in the academic sector and also in the management of business, Patterson said. Those mentors include seasoned industry veterans who know what it takes to take a drug from bench to bedside, and who understand patenting and licensing.

The next step for Auxolytic, scientifically, is to identify potential applications around selecting for differentiated cells from induced pluripotent stem cells (iPSCs). Much of the scientific work is being done in collaboration with the Matthew H. Porteus lab at Stanford University.

On the business side, he continued, Were excited to get this into the hands of big cell therapy companies that currently are making cell therapies without a safety switch. Were looking to partner with them to get this to patients.

Auxolytic is talking with several interested companies. People recognize the need for a safety switch and are very excited, Patterson said. Discussions are going well.

Read more from the original source:
Auxolytic's Nutrient-Based Shut-Off Switch Boosts Cell Therapy Safety Without Transgenes - BioSpace

New discovery explains how coronavirus may be able to infect cells – Health24

Early in the Covid-19 outbreak, Health24 wrote about the novel coronavirus and how it uses its spikes to dock onto the surface of human cells with the help of a receptor called ACE2.

Vaccine developers have centred their research around these spike proteins and ACE2 receptors, as it provided insight into how the virus triggers an immune response in humans.

According to a news release, German scientists including experts from of the European Molecular Biology Laboratory (EMBL) in Heidelberg, the Max Planck Institute of Biophysics, the Paul-Ehrlich-Institut, and Goethe University Frankfurt have been focusing on the surface structure of the virus to gain insights they can use for the development of vaccines and therapies to treat infected patients.

A flexible stalk

The team used a combination of cryo-electron tomography, subtomogram averaging and molecular dynamics simulations to analyse the exact molecular structure of the spike protein.

Their data showed that the globular portion of the spike protein, where the receptor-binding region is situated and helps the virus to successfully bind to human cells, is actually connected to a flexible stalk.

"The stalk was expected to be quite rigid," said Gerhard Hummer from the MPI of Biophysics and the Institute of Biophysics at Goethe University Frankfurt in a news release. "But in our computer models and in the actual images, we discovered that the stalks are extremely flexible.

The researchers were able to identify that the stalk had three hinges that give it its flexibility.

"Like a balloon on a string, the spikes appear to move on the surface of the virus and thus are able to search for the receptor for docking to the target cell," explains Jacomine Krijnse Locker, group leader at the Paul-Ehrlich-Institut.

What does this mean for future vaccine development?

The new research didnt only identify the flexibility of the spike protein, but also discovered that the entire protein, including the stalk, is coated with sugar-like molecules called glycans, which protect the spikes from antibodies.

This protective layer is an important discovery for vaccine and treatment development.

READ | Mutation helps coronavirus infect more cells, study shows

READ | How the coronavirus infects: It can make itself unrecognisable to cells in the body

READ | New coronavirus wasn't made in a lab, genomic study shows

Image credit: Getty Images

See the original post:
New discovery explains how coronavirus may be able to infect cells - Health24

Market trends and outlook coupled with factors driving and restraining the growth of the Cell Imaging Systems market – Scientect

The most advanced study released by AMR on the Cell Imaging Systems market comprising key market segments such as Type, Application, Sales, Growth, Comprises details of companies manufacturing field, production volume, capacities, value chain, product specifications, raw material sourcing strategies, concentration rate, organizational structure, and distribution channel.

The COVID-19 outbreak is now traveling around the world, leaving a trail of destruction in its wake. This report discusses the impact of the virus on leading companies in the Cell Imaging Systems sector.

The research is a precise offset bridging both qualitative and quantitative data of Cell Imaging Systems market.

The study provides historical data to compare for evolving Sales, Revenue, Volume, Value of 2014 to 2019 and forecasted till 2026.

It becomes necessary to analyze the competitors progress while operating into the same competing environment, for that purpose, the report provides thorough insights into market competitors marketing strategies which include alliances, acquisitions, ventures, partnerships, as well as product launches, and brand promotions.

Cell Imaging Systems Market with Impact Analysis of COVID-19: Key Major Players areCarl Zeiss Microscopy, Etaluma, Inc, Thermo Fisher, Lumenera Corporation, Lonza, Molecular Devices LLC, GE Healthcare Life Science, Logos Biosystems, Perkin Elmer, Bio-Rad, Keyence Corporation, BioTek, Leica Microsystems, Nikon Instruments Inc..

Sample PDF Copy Instantly in your email box at: https://www.amplemarketreports.com/sample-request/covid-19-outbreak-global-cell-imaging-systems-industry-1957105.html

Cell Imaging Systems Research objectives

Focuses on the key global Cell Imaging Systems players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next few years.

Competitive Structure and analysis of The Cell Imaging Systems Market:

Some of the players have a stellar growth track record for 2014 to 2018, some of these companies have shown tremendous growth by sales and revenue while net income more than doubled in the same period with performing as well as gross margins expanding. The growth in gross margins over the years points to strong pricing power by the company for its products, over and above the increase in the cost of goods sold.

The report further features analysis that contains details of companies manufacturing base, production volume, sizes, value chain, product specifications.

According to AMR, key market segments sales will traverse the $$ mark in the year 2020. Unlike classified segments by Type (Confocal Microscopy, Phase Contrast Microscopy, Fluorescent Microscopy, Quantitative Phase Contrast Microscopy), by End-Users/Application (Drug Discovery, Stem Cells, Cell Biology, Developmental Biology).

2020 report version is the most advanced which is further divided and highlights a new emerging twist of the industry.

Cell Imaging Systems market will increase from $XX million in 2019 to strike $YY million by 2026, with a compound annual growth rate (CAGR) of xx%. The most robust growth is anticipated in Asia-Pacific, where CAGR is presumed to be ##% from 2019 to 2026. This prediction is good news for market players, as there is good potential for them to continue developing alongside the industrys projected growth.

Find out more on growth of Cell Imaging Systems market at: https://www.amplemarketreports.com/report/covid-19-outbreak-global-cell-imaging-systems-industry-1957105.html

Market players have determined strategies to offer a whole host of new product launches within several markets around the globe. Remarkable models are variant to be launched in eight EMEA markets in Q4 2019 and 2020. Acknowledging all-around exercises some of the players profiles that would be worth reviewing are Carl Zeiss Microscopy, Etaluma, Inc, Thermo Fisher, Lumenera Corporation, Lonza, Molecular Devices LLC, GE Healthcare Life Science, Logos Biosystems, Perkin Elmer, Bio-Rad, Keyence Corporation, BioTek, Leica Microsystems, Nikon Instruments Inc..

Although recent years might not be that inspiring as market segments have registered reasonable gains, things could have been better if manufacturers would have plan-driven move earlier. Unlike past, but with a decent estimate, investment cycle continuing to progress in the U.S., many growth opportunities ahead for the companies in 2020, it looks like a good for today but stronger returns can be expected beyond.

Get to know about Discount at: https://www.amplemarketreports.com/discount-request/covid-19-outbreak-global-cell-imaging-systems-industry-1957105.html

Report Answers Following Questions:

Thanks for reading this article, you can also get individual chapter wise section or region wise report versions like North America, Western / Eastern Europe or Southeast Asia.

With the given market data, Research on Global Markets offers customization according to specific needs.

About Author

Ample Market Research provides comprehensive market research services and solutions across various industry verticals and helps businesses perform exceptionally well. Our end goal is to provide quality market research and consulting services to customers and add maximum value to businesses worldwide. We desire to deliver reports that have the perfect concoction of useful data. Our mission is to capture every aspect of the market and offer businesses a document that makes solid grounds for crucial decision making.

Contact Address:

William James

Media & Marketing Manager

Address: 3680 Wilshire Blvd, Ste P04 1387 Los Angeles, CA 90010

Call: +1 (530) 868 6979

Email: [emailprotected]

https://www.amplemarketreports.com

Read this article:
Market trends and outlook coupled with factors driving and restraining the growth of the Cell Imaging Systems market - Scientect

The global market for Peripheral Blood Mononuclear Cells (PBMC) is projected to grow at a CAGR of around 9% during 2020 – 2025 – GlobeNewswire

New York, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Peripheral Blood Mononuclear Cells Market, By Product, By Application, By Technique, By Source, By Region, Competition, Forecast & Opportunities, 2025" - https://www.reportlinker.com/p05953172/?utm_source=GNW

The global market for Peripheral Blood Mononuclear Cells (PBMC) is projected to grow at a CAGR of around 9% during 2020 - 2025.The PBMC are crucial to carry out the biology and pathology related studies as well as in clinical research.

Besides, PBMCs are also utilized in research related to fatal diseases, immunology, vaccine development, etc. However, high cost of PBMCs related studies might act as a challenge for the adoption of technology, especially in developing economies. The global peripheral blood mononuclear cells market is segmented based on product, application, technique, source, and region.The product segment is further divided into cryopreserved or frozen PBMC, cultured or fresh PBMC and peripheral blood mononuclear cell isolation & viability kits.

As of 2019, the cryopreserved PBMC or the frozen PBMC segment held the highest market share as they can be used for longer durations of time if stored carefully at lower temperatures.In terms of regional analysis, North America accounted for the largest market share in the year 2019, on the back of a number of pre-existing peripheral blood mononuclear cells-based companies in the region.

The economy of the region is also rich enough, which makes it easier to carry out the complex and costly R&D procedures. Major players operating in the global peripheral blood mononuclear cells market include Astarte Biologics, Inc., ATZLabs, BioIVT, BioLegend, Inc., BioVision, Bio-Rad, Cell Applications, Inc., Celgene, Creative Bioarray, Dapcel, Inc, HemaCare, iXCells Biotechnologies, Miltenyi Biotec, Merck, Novo Nordisk, Precision Medicine, Qiagen NV, STEMCELL Technologies Inc., Thermo Fisher Scientific, ZenBio, Inc., etc.

Years considered for this report:

Historical Years: 2015 - 2018 Base Year: 2019 Estimated Year: 2020 Forecast Period: 2021 - 2025

Objective of the Study:

To analyze and forecast the market size of global peripheral blood mononuclear cells market. To classify and forecast global peripheral blood mononuclear cells market based on product, application, technique, source, and region. To identify drivers and challenges for global peripheral blood mononuclear cells market. To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global peripheral blood mononuclear cells market. To conduct pricing analysis for global peripheral blood mononuclear cells market. To identify and analyze the profile of leading players operating in global peripheral blood mononuclear cells market. The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of leading market players across the globe.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the research organizations and companies which could not be identified due to the limitations of secondary research. The analyst examined the research organizations and companies, and presence of all major players across the globe. The analyst calculated the market size of global peripheral blood mononuclear cells market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

Biotechnology and pharma companies and other stakeholders Government bodies such as regulating authorities and policy makers Organizations, forums and alliances related to peripheral blood mononuclear cells Market research and consulting firms The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as research organizations & companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global peripheral blood mononuclear cells market has been segmented into following categories, in addition to the industry trends which have also been detailed below: Market, By Product: o Cryopreserved or Frozen PBMC o Cultured or Fresh PBMC o Peripheral Blood Mononuclear Cell Isolation & Viability Kits Market, By Application: o Immunology o Infectious disease o Hematology o Others Market, By Technique: o Density gradient centrifugation process o Leukapheresis Market, By Source: o Human o Animals Market, By Region: o Asia-Pacific - China - India - Japan - South Korea - Singapore - Australia o Europe - France - Germany - United Kingdom - Italy o North America - United States - Mexico - Canada o South America - Brazil - Argentina - Colombia o Middle east & Africa - South Africa - Saudi Arabia - UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global peripheral blood mononuclear cells market.

Available Customizations:

With the given market data, we offers customizations according to a companys specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).Read the full report: https://www.reportlinker.com/p05953172/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

View original post here:
The global market for Peripheral Blood Mononuclear Cells (PBMC) is projected to grow at a CAGR of around 9% during 2020 - 2025 - GlobeNewswire

Regeneration of vascular cells is regulated by RNA-binding protein – News-Medical.net

Through their basic research, physicians at the Heart Center of the University Hospital Bonn have discovered how the communication between individual cells can be influenced with the help of a specific protein.

These findings are an important approach to improving the treatment of diseases such as arteriosclerosis (calcified blood vessels), which causes heart attacks. The study was published online in advance in the Journal of Extracellular Vesicles, the printed version will be published shortly.

The human body consists of an inconceivably large number of cells. Current scientific studies assume around 40 trillion cells, depending on the weight and size of the person.

Most cells come together to perform their function in the body in the best possible way. Collectively they form tissue, organs and muscles. The most important requirement for good cellular interaction is for the cells to communicate with each other as effectively as possible.

In order for cells to communicate effectively with each other, they need a postman to carry information from one cell to the next. This is precisely the role played by extracellular vesicles."

Dr Andreas Zietzer, Cardiologist, Heart Center, Bonn University Hospital

For a long time, these vesicles were considered to have little biological significance. It was assumed that the vesicles were only used to get rid of excess proteins and other molecules, making them a kind of cellular garbage disposal. However, it is now known that vesicles play a key role in intercellular communication.

The principle of the vesicles can be explained quite simply: They are released as extremely small membrane bubbles - only about two thousandths of a millimeter in size - by cells in our body and can then be taken up and utilized by other cells.

Zietzer describes the crucial function of the vesicles "as postmen, they transport various contents and thereby enable the exchange of information between cells."

In addition to proteins and lipids, this communication process also involves transporting ribonucleic acids (RNAs). These RNAs are copies of the genetic information and are required for carrying out its function.

The physicians at the University of Bonn concentrated their research primarily on so-called microRNAs, which are responsible for fine tuning the switching on and off of genes.

"Because microRNAs have considerable influence on the biology of the cells, vesicles can influence the function of recipient cells depending on their specific cargo," says Zietzer.

This is because, depending on which microRNA is enriched in the vesicles, the information transported by the vesicles also changes and with it the effect on the recipient cells that take up the vesicles and their cargo.

"It would be a breakthrough for researchers and physicians if they could control which information is transported between cells and which is not," says Zietzer, looking to the future. "However, precisely this kind of manipulation of cell-to-cell communication has so far been barely investigated."

The research group, led by Dr. Andreas Zietzer, Dr. Rabiul Hosen and Dr. Felix Jansen (head of the research group), at the Heart Center of the University Hospital Bonn has now succeeded in using a new mechanism on human cells to clarify how the sorting of specific RNAs within the vesicles works.

To this end, the researchers used a mass spectrometer to identify more than 3,000 proteins and 300 microRNAs that were found to be enclosed in the vesicles and ready for transport to other cells.

The three researchers were able to show that a specific RNA-binding protein (hnRNPU for short) retains the microRNAs in the donor cell like a sponge, thereby preventing them from being packed into vesicles and transported to another cell.

The exact opposite is true when this particular protein is switched off: In this case there is an elevated release of the microRNAs, which are then increasingly packed into the vesicles.

"The RNA-binding protein hnRNPU therefore assumes the role of a gatekeeper, deciding which and how many microRNAs are released from the donor cell for transport to the recipient cell," Andreas Zietzer summarizes the research results. This function enables the protein hnRNPU to significantly influence the communication between cells.

These observations hold great therapeutic potential; Zietzer, Hosen and Jansen were able to show that the transfer of certain microRNAs via the vesicles can be controlled by increasing or reducing the amount of hnRNPU in the donor cells.

"This enables a targeted release, or retention, of microRNAs that promote regeneration and thereby positively or negatively influence the regenerative ability of diseased vascular cells," comments Zietzer on the potential intervention in cellular communication.

Medically, this is of high importance, as the regenerative ability of the vascular cells in calcified vessels (arteriosclerosis) is already limited in the early stages of the disease.

Zietzer, Hosen, and Jansen now hope to apply their findings on intercellular communication using extracellular vesicles: "It is, for instance, conceivable that the targeted local activation or deactivation of the protein hnRNPU in healthy parts of the vascular system might lead to a 'swarm' of regeneration-promoting vesicles to be dispatched, which could then be taken up by already damaged vascular areas and accelerate regeneration there. In critical situations, such as after a heart attack, this could promote the healing process of patients," says Zietzer about the concrete benefit of this basic research.

Further applicability studies are in progress. The current research results suggest that this mechanism is also of great importance in the progression of heart and kidney diseases.

The costs for this research of approximately 300,000 euros were provided by the German Research Foundation, the German Cardiac Society, the Corona Foundation, and the Faculty of Medicine of the University of Bonn.

Source:

Journal reference:

Zietzer, A., et al. (2020) The RNA-binding protein hnRNPU regulates the sorting of microRNA-30c-5p into large extracellular vesicles. Journal of Extracellular Vesicles. doi.org/10.1080/20013078.2020.1786967.

Continue reading here:
Regeneration of vascular cells is regulated by RNA-binding protein - News-Medical.net